Thermo Fisher Scientific Inc. (tmo)
TMO — Company Overview
Thermo Fisher Scientific Inc. (TMO) is a mega-cap company in the Healthcare sector, operating in Diagnostics & Research.
| Ticker | TMO |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Exchange | NYQ |
| Market cap | $214.46B |
| Last price | $580.02 |
| Size category | Mega Cap |
TMO — Business Description
Thermo Fisher Scientific Inc. (TMO) operates in Diagnostics & Research within the broader Healthcare market. Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other res…
Official website: https://www.thermofisher.com.
TMO — Investment Thesis
The investment thesis for Thermo Fisher Scientific Inc. (TMO) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.
- Revenue is expanding at roughly 10.5% year-over-year (public data).
- Trailing P/E of 31.05× sits in a moderate band relative to high-growth peers.
- Forward P/E (21.08×) is below trailing P/E — earnings may be expected to improve.
- Equity market capitalization is approximately $214.46B.
Analyst consensus, price targets & estimates is available in Vest Terminal for Professional and Enterprise subscribers.
TMO — Financial Health
Financial health for Thermo Fisher Scientific Inc. (TMO) is summarized from publicly reported profitability, leverage, and cash-flow metrics.
Profit margin of 15.0% indicates solid bottom-line conversion. Positive free cash flow of $6.24B supports balance-sheet flexibility.
| Trailing P/E | 31.05× |
| Forward P/E | 21.08× |
| Price / Sales | 4.63× |
| Price / Book | 4.15× |
| Gross margin | 41.0% |
| Operating margin | 18.8% |
| Profit margin | 15.0% |
| Return on equity | 13.5% |
| Debt / Equity | 80.58 |
| Free cash flow | $6.24B |
TMO — Growth Outlook
Growth outlook for Thermo Fisher Scientific Inc. (TMO) depends on demand trends in Diagnostics & Research and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 10.5% indicates strong top-line momentum.
- Earnings growth of 9.4% year-over-year supports improving profitability.
- Price is 9.9% below the 52-week high.
TMO — Competitive Position
Thermo Fisher Scientific Inc. (TMO) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Diagnostics & Research.
- Market capitalization of $214.46B places TMO among mega-cap peers.
- Gross margin near 41.0% may reflect pricing power or favorable mix.
TMO — Strengths
Strengths for Thermo Fisher Scientific Inc. (TMO) inferred from public financial metrics:
- Revenue growth of 10.5% year-over-year.
- Earnings growth of 9.4% year-over-year.
- Gross margin of 41.0% supports competitive unit economics.
- Positive free cash flow ($6.24B).
- Mega Cap scale ($214.46B) may provide distribution and funding advantages.
TMO — Weaknesses
Weaknesses and pressure points for Thermo Fisher Scientific Inc. (TMO) based on available data:
Insufficient public data to assess this factor.
TMO — Opportunities
- Sustained revenue growth (10.5%) could support multiple expansion if margins hold.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
TMO — Risks
- Standard market, regulatory, competitive, and execution risks apply to all public equities.
TMO — Summary
Thermo Fisher Scientific Inc. (TMO) is a mega-cap Healthcare company focused on Diagnostics & Research, listed on NYQ. Last price $580.02 with market cap $214.46B. Trailing P/E 31.05×. Revenue grew 10.5% year-over-year per public data. Notable strengths include revenue growth of 10.5% year-over-year. Detailed estimates, ownership, and news for Thermo Fisher Scientific Inc. remain locked in Vest Terminal for subscribers.
Thermo Fisher Scientific Inc. FAQ
What does Thermo Fisher Scientific Inc. (TMO) do?
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostic…
What is TMO's P/E ratio?
Thermo Fisher Scientific Inc. has a trailing P/E of 31.05× based on publicly available market data.
Does TMO pay a dividend?
Indicated dividend yield: 0.3%. Confirm ex-dates and payout history in Vest Terminal.
What sector is TMO in?
Thermo Fisher Scientific Inc. is classified in Healthcare (Diagnostics & Research) on NYQ.
What is TMO's market capitalization?
Approximate market cap: $214.46B.
What are the main risks for TMO?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of TMO?
Potential positives include revenue growth of 10.5% year-over-year, earnings growth of 9.4% year-over-year.
Where can I get analyst estimates for TMO?
Consensus estimates, price targets, and detailed analyst data for Thermo Fisher Scientific Inc. are available to Professional subscribers in Vest Terminal — not on this public summary page.